JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB182561

Anti-ARID1A antibody [EPR13501-73]

  • Recombinant
  • KO Validated
  • Advanced Validation
  • RabMAb
  • What is this?

5

(1 Review)

|

(10 Publications)

Anti-ARID1A antibody [EPR13501-73] (ab182561) is a rabbit monoclonal antibody detecting ARID1A in Western Blot, Flow Cytometry (Intra), IHC-P, ICC/IF. Suitable for Human.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency

View Alternative Names

BAF250, BAF250A, C1orf4, OSA1, SMARCF1, ARID1A, AT-rich interactive domain-containing protein 1A, ARID domain-containing protein 1A, B120, BRG1-associated factor 250, BRG1-associated factor 250a, Osa homolog 1, SWI-like protein, SWI/SNF complex protein p270, hELD, hOSA1

10 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ARID1A antibody [EPR13501-73] (AB182561)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ARID1A antibody [EPR13501-73] (AB182561)

Immunohistochemical analysis of paraffin-embedded Human adenocarcinoma of endometrium without ARID1A mutation (left image) labeling ARID1A using ab182561 at 1/1000 dilution. Right image : human adenocarcinoma of endometrium with ARID1A mutation. A Ready to use HRP Polymer for Rabbit IgG (prediluted) was used as secondary. Counterstain : Hematoxylin.

Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.

Flow Cytometry (Intracellular) - Anti-ARID1A antibody [EPR13501-73] (AB182561)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-ARID1A antibody [EPR13501-73] (AB182561)

Intracellular Flow Cytometry analysis of SH-SY5Y (human neuroblastoma) cells labeling ARID1A with purified ab92512 at 1/500 dilution (10ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.

Immunocytochemistry/ Immunofluorescence - Anti-ARID1A antibody [EPR13501-73] (AB182561)
  • ICC/IF

Collaborator

Immunocytochemistry/ Immunofluorescence - Anti-ARID1A antibody [EPR13501-73] (AB182561)

ab182561 was shown to react with ARID1A in wild-type HAP1 cells in immunocytochemistry with loss of signal observed in a ARID1A knockout cell line. Wild-type and knockout cells were mixed and pelleted at a 1 : 1 ratio on coverslips. The cells were fixed with 4% paraformaldehyde (15 min) then permeabilized with 0.1% Triton X-100 (10min) and then blocked with 1x PBS, 0.01% Triton X-100, 5% BSA, 5% NGS. The cells were then incubated with ab182561 at 1/250 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat anti-rabbit secondary antibody to (Alexa Fluor® 555) at 0.5 µg/ml. Acquisition of the green (wild-type), red (antibody staining) and far-red (knockout) channels was performed. Representative grayscale images of the red channel are shown. Wild-type and knockout cells are outlined with yellow and magenta dashed line, respectively. Schematic representation of the mosaic strategy used is shown on the bottom-right panel. Image was acquired with a Zeiss(LSM-880).

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ARID1A antibody [EPR13501-73] (AB182561)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ARID1A antibody [EPR13501-73] (AB182561)

Immunohistochemical analysis of paraffin-embedded Human kidney tissue (left image) labeling ARID1A using ab182561 at 1/1000 dilution. Right image : human clear cell carcinoma of kidney with ARID1A mutation. A Ready to use HRP Polymer for Rabbit IgG (prediluted) was used as secondary. Counterstain : Hematoxylin.

Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.

Immunocytochemistry/ Immunofluorescence - Anti-ARID1A antibody [EPR13501-73] (AB182561)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-ARID1A antibody [EPR13501-73] (AB182561)

Immunofluorescent analysis of SH-SY5Y cells labeling ARID1A with ab182561 at 1/500 and Goat anti rabbit IgG(Alexa Fluor®555) at 1/200. Image at the right stained with DAPI.

Immunoprecipitation - Anti-ARID1A antibody [EPR13501-73] (AB182561)
  • IP

Collaborator

Immunoprecipitation - Anti-ARID1A antibody [EPR13501-73] (AB182561)

Immunoprecipitation of ARID1A in HAP1 cells. Lysates were prepared and immunoprecipitation was performed using 2 μg of ab182561 pre-coupled to Protein A beads. Samples were then washed and processed for western blot.

This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ARID1A antibody [EPR13501-73] (AB182561)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ARID1A antibody [EPR13501-73] (AB182561)

Immunohistochemical analysis of paraffin-embedded Rat spleen tissue labeling ARID1A with ab182561 at 1/4000 dilution followed by a Goat Anti-Rabbit IgG H&L (HRP polymer) - ready to use.

Positive staining on mouse spleen.

The primary antibody was incubated at 4°C overnight.

Counterstained with Hematoxylin.

Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ARID1A antibody [EPR13501-73] (AB182561)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ARID1A antibody [EPR13501-73] (AB182561)

Immunohistochemical analysis of paraffin-embedded Mouse spleen tissue labeling ARID1A with ab182561 at 1/4000 dilution followed by a Goat Anti-Rabbit IgG H&L (HRP polymer) - ready to use.

Positive staining on mouse spleen.

The primary antibody was incubated at 4°C overnight.

Counterstained with Hematoxylin.

Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0).

Western blot - Anti-ARID1A antibody [EPR13501-73] (AB182561)
  • WB

Supplier Data

Western blot - Anti-ARID1A antibody [EPR13501-73] (AB182561)

Blocking and diluting buffer : 5% NFDM/TBST ARID1A has many mutations which typically generate truncated proteins that are highly prone to degradation. (PMID : 21614196, PMID : 29486633, PMID : 34429326).

All lanes:

Western blot - Anti-ARID1A antibody [EPR13501-73] (ab182561) at 1/1000 dilution

Lane 1:

ARID1 knockout HAP1 (Human chronic myelogenous leukemia near-haploid cell line) treated with 10uM MG-132 for 6 hours whole cell lysate at 20 µg

Lane 2:

Wild-type HAP1 (Human chronic myelogenous leukemia-haploid cell line) treated with 10uM MG-132 for 6 hours whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 242 kDa

Observed band size: 130-270 kDa

false

Exposure time: 10s

ChIC/CUT&RUN sequencing - Anti-ARID1A antibody [EPR13501-73] (AB182561)
  • ChIC/CUT&RUN-seq

Supplier Data

ChIC/CUT&RUN sequencing - Anti-ARID1A antibody [EPR13501-73] (AB182561)

ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 10^5 HCT116 cells and 5µg of ab182561 [EPR13501-73]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.

  • Carrier free

    Anti-ARID1A antibody [EPR13501-73] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR13501-73

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

IHC-P, ChIC/CUT&RUN-seq, ICC/IF, Flow Cyt (Intra), WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ChICCUTRUNseq" : {"fullname" : "ChIC/CUT&RUN sequencing", "shortname":"ChIC/CUT&RUN-seq"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ChICCUTRUNseq-species-checked": "testedAndGuaranteed", "ChICCUTRUNseq-species-dilution-info": "5 µg", "ChICCUTRUNseq-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Mouse": { "ChICCUTRUNseq-species-checked": "guaranteed", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/4000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Rat": { "ChICCUTRUNseq-species-checked": "guaranteed", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/4000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

What is this antibody validated in?
Anti-ARID1A antibody [EPR13501-73] (ab182561) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

What is the molecular weight of ARID1A?
Anti-ARID1A [EPR13501-73] (ab182561) specifically detects a band for ARID1A (UniProt: O14497) at a molecular weight of 242kDa.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-ARID1A antibody [EPR13501-73] (ab182561) has been confirmed by Western blot testing in ARID1A Knockout HAP1 cell line.

Other related products
We have a range of other formats of antibody clone [EPR13501-73] also available for your convenience: ab182561, Carrier free - ab250617

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ARID1A also known as BAF250A is a protein encoded by the ARID1A gene and forms part of the SWI/SNF chromatin remodeling complex. The molecular weight of ARID1A is approximately 270 kDa. This protein is expressed in many tissues but higher expression is noted in the liver kidney and placenta. ARID1A contains an ARID (A-T Rich Interaction Domain) which allows it to bind DNA influencing transcription regulation significantly.
Biological function summary

ARID1A impacts cellular functions through its role in the SWI/SNF complex. This complex modulates chromatin structure and is integral to DNA accessibility which in turn controls gene expression. ARID1A's involvement helps in regulating transcription factors and affects processes such as cell growth and differentiation. Its function is necessary for maintaining proper cell proliferation and apoptosis balance.

Pathways

ARID1A plays a central role in transcriptional regulation and cell cycle control. It shows interaction with the tumor suppressor protein p53 and is implicated in the PI3K/AKT signaling pathway. ARID1A's function in these pathways affects cellular responses to DNA damage and growth signals linking it closely to important cellular fate decisions.

Mutations or loss of function in ARID1A has been strongly associated with various cancers including ovarian and endometrial cancers. In these contexts ARID1A dysfunction often occurs alongside other proteins such as p53 contributing to tumorigenesis by deregulating tumor suppressive pathways. It also holds a potential connection to neurodevelopmental disorders due to its role in chromatin remodeling and gene expression.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Binds DNA non-specifically. Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity).
See full target information ARID1A

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Journal of experimental & clinical cancer research : CR 44:97 PubMed40082916

2025

Viral expression of NE/PPE enhances anti-colorectal cancer efficacy of oncolytic adenovirus by promoting TAM M1 polarization to reverse insufficient effector memory/effector CD8 T cell infiltration.

Applications

Unspecified application

Species

Unspecified reactive species

Shuo Wang,Lingkai Kong,Linpei Wang,Yan Zhuang,Ciliang Guo,Yuxin Zhang,Huawei Cui,Xiaosong Gu,Junhua Wu,Chunping Jiang

Immunity 56:1303-1319.e5 PubMed37315534

2023

Canonical BAF complex activity shapes the enhancer landscape that licenses CD8 T cell effector and memory fates.

Applications

Unspecified application

Species

Unspecified reactive species

Bryan McDonald,Brent Y Chick,Nasiha S Ahmed,Mannix Burns,Shixin Ma,Eduardo Casillas,Dan Chen,Thomas H Mann,Carolyn O'Connor,Nasun Hah,Diana C Hargreaves,Susan M Kaech

Cancer immunology research 10:1326-1339 PubMed36095166

2022

The Tumor Microenvironment of Clear-Cell Ovarian Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Michael-John Devlin,Rowan Miller,Florian Laforets,Panoraia Kotantaki,Dale W Garsed,Rebecca Kristeleit,David D Bowtell,Jacqueline McDermott,Eleni Maniati,Frances R Balkwill

Nature communications 13:1898 PubMed35393414

2022

Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Marie-Eve Wedge,Victoria A Jennings,Mathieu J F Crupi,Joanna Poutou,Taylor Jamieson,Adrian Pelin,Giuseppe Pugliese,Christiano Tanese de Souza,Julia Petryk,Brian J Laight,Meaghan Boileau,Zaid Taha,Nouf Alluqmani,Hayley E McKay,Larissa Pikor,Sarwat Tahsin Khan,Taha Azad,Reza Rezaei,Bradley Austin,Xiaohong He,David Mansfield,Elaine Rose,Emily E F Brown,Natalie Crawford,Almohanad Alkayyal,Abera Surendran,Ragunath Singaravelu,Dominic G Roy,Gemma Migneco,Benjamin McSweeney,Mary Lynn Cottee,Egon J Jacobus,Brian A Keller,Takafumi N Yamaguchi,Paul C Boutros,Michele Geoffrion,Katey J Rayner,Avijit Chatterjee,Rebecca C Auer,Jean-Simon Diallo,Derrick Gibbings,Benjamin R tenOever,Alan Melcher,John C Bell,Carolina S Ilkow

Molecular oncology 16:2235-2259 PubMed35167193

2022

ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Cristina Megino-Luque,Pol Sisó,Natalia Mota-Martorell,Raúl Navaridas,Inés de la Rosa,Izaskun Urdanibia,Manel Albertí-Valls,Maria Santacana,Miquel Pinyol,Núria Bonifaci,Anna Macià,David Llobet-Navas,Sònia Gatius,Xavier Matias-Guiu,Núria Eritja

Diagnostic cytopathology 50:8-17 PubMed34783431

2021

Application of immunocytochemical and molecular analysis of six genes in liquid-based endometrial cytology.

Applications

Unspecified application

Species

Unspecified reactive species

Satoru Munakata,Toshiya Yamamoto

Cell reports 35:108964 PubMed33826897

2021

Arid1a-Plagl1-Hh signaling is indispensable for differentiation-associated cell cycle arrest of tooth root progenitors.

Applications

Unspecified application

Species

Unspecified reactive species

Jiahui Du,Junjun Jing,Yuan Yuan,Jifan Feng,Xia Han,Shuo Chen,Xiang Li,Weiqun Peng,Jian Xu,Thach-Vu Ho,Xinquan Jiang,Yang Chai

American journal of clinical pathology 152:463-470 PubMed31263894

2019

Associations Between Loss of ARID1A Expression and Clinicopathologic and Genetic Variables in T1 Early Colorectal Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yoshihiro Kishida,Takuma Oishi,Takashi Sugino,Akio Shiomi,Kenichi Urakami,Masatoshi Kusuhara,Ken Yamaguchi,Yuko Kitagawa,Hiroyuki Ono

eLife 8: PubMed31259687

2019

Antagonistic interaction between Ezh2 and Arid1a coordinates root patterning and development via Cdkn2a in mouse molars.

Applications

Unspecified application

Species

Unspecified reactive species

Junjun Jing,Jifan Feng,Jingyuan Li,Xia Han,Jinzhi He,Thach-Vu Ho,Jiahui Du,Xuedong Zhou,Mark Urata,Yang Chai

Cancer cell 33:137-150.e5 PubMed29290541

2018

Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Kie Kyon Huang,Kalpana Ramnarayanan,Feng Zhu,Supriya Srivastava,Chang Xu,Angie Lay Keng Tan,Minghui Lee,Suting Tay,Kakoli Das,Manjie Xing,Aliya Fatehullah,Syed Muhammad Fahmy Alkaff,Tony Kiat Hon Lim,Jonathan Lee,Khek Yu Ho,Steven George Rozen,Bin Tean Teh,Nick Barker,Chung King Chia,Christopher Khor,Choon Jin Ooi,Kwong Ming Fock,Jimmy So,Wee Chian Lim,Khoon Lin Ling,Tiing Leong Ang,Andrew Wong,Jaideepraj Rao,Andrea Rajnakova,Lee Guan Lim,Wai Ming Yap,Ming Teh,Khay Guan Yeoh,Patrick Tan
View all publications
chicCutRunSequencingBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com